BLPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Bellerophon Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.1025 USD

Market Cap: $146.8k

	Bellerophon Therapeutics Inc OTC:BLPH	US
	Moderna Inc LSE:0A45	US
	Taiwan Semiconductor Manufacturing Co Ltd NYSE:TSM	TW
	Yakult Honsha Co Ltd TSE:2267	JP

Profitability Summary

Bellerophon Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-196%

Negative 3Y Average Operating Margin

-222%

Operating Margin is Increasing

-248% > -196%

Negative Net Margin

-164%

Negative 3Y Average Net Margin

-192%

Net Margin is Increasing

-220% > -164%

Negative Free Cash Flow Margin

-219%

Negative 3Y Average Free Cash Flow Margin

-207%

Declining Free Cash Flow Margin

-195% > -219%

Negative ROE

-166%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

4 590%

ROIC is Increasing

1 391% > 7 788%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.